BridgeBio Oncology Therapeutics Inc.

NASDAQ:BBOT

Biotechnology

Healthcare
$1.81 -0.39%

-$0.03 today

Market cap
$144.85M
Beta
0.29
P/E (TTM)
-1.5
EPS (TTM)
-$4.95
52W Low $7.00High $14.87

Volume 0.58M

Average 0.37M

BBOT Pre-Tax Margin

Income before tax as a percentage of revenue.

No reported Pre-Tax Margin figures are available to summarize.

Pre-Tax Margin history

Percent of revenue · from the income statement

No Pre-Tax Margin data reported for this period type.

Pre-Tax Margin vs competitors

How BBOT compares with its peers on the latest reported figures

BBOT Competitors Peer median
Pre-Tax Margin for BBOT and competitors
Company Period LTM level YoY 3-year change
NRIXNurix Therapeutics, Inc.LTM Aug 202643.9% +335.5 pp+152.9 pp
ANABAnaptysBio, Inc.LTM Mar 2026-11.5% +114.2 pp+1245.5 pp
SEPNSepterna, Inc.LTM Sep 2026-55.1% +212.4 pp—
PHATPhathom Pharmaceuticals, Inc.LTM Mar 2026-76.8% +345.6 pp—
URGNUroGen Pharma Ltd.LTM Mar 2026-98.4% +48.8 pp+28.1 pp
XNCRXencor, Inc.LTM Jun 2026-153.2% -43.9 pp-38.1 pp
TNGXTango Therapeutics, Inc.FY2025-162.8% +146.4 pp+272.1 pp
OCSOculis Holding AGLTM Mar 2026-18919.2% ——
BBOTBridgeBio Oncology Therapeutics Inc.FY2025— ——
KODKodiak Sciences Inc.FY2025— ——
Peer median (excluding BBOT) -87.6%+146.4 pp+152.9 pp

Competitors are the stored peer set for BBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development0056.29M73.11M121.2M
Selling, General & Admin43.36K3.52K8.49M7.76M24.62M
Operating Expenses43.36K3.52K64.77M80.86M145.82M
Depreciation & Amortization74.33K3.52K92K208K610K
EBITDA(43.36K)(3.52K)(64.68M)(80.66M)(145.21M)
EBITDA Margin—————
Operating Income(43.36K)(3.52K)(64.77M)(80.86M)(145.82M)
Operating Margin—————
Interest Income0072K8.46M11.34M
Interest Expense00000
Other Income / Expenses0072K8.18M11.78M
Income Before Tax(43.36K)(3.52K)(64.7M)(74.28M)(134.04M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(43.36K)(3.52K)(64.7M)(74.28M)(134.04M)
Net Margin—————
EPS (Basic)(0.00)0.00(3.16)0.46(4.30)
EPS (Diluted)(0.00)(0.00)(3.16)0.46(4.30)
Weighted Avg Shares20.49M20.49M20.49M16.64M31.14M
Weighted Avg Shares (Diluted)20.49M20.49M20.49M16.64M31.14M

BridgeBio Oncology Therapeutics Inc.

NASDAQ:BBOT

Intrinsic Alpha fair value

Locked

Current Price

$1.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.